Allogene Therapeutics plans to attend three investor conferences
ALLO•Allogene Therapeutics plans to participate in three investor conferences: two in London on Nov. 16 and 18, 2026, and one in New York on Dec. 2, 2026.
1. Conference schedule
Allogene Therapeutics is scheduled to attend the UBS Global Biopharma Conference in London on Nov. 16, 2026, at 11:20 a.m. GMT / 6:20 a.m. ET, and the Jefferies Global Healthcare Conference in London on Nov. 18 at 9:30 a.m. GMT / 5:30 a.m. ET. The company is also set to appear at the Piper Sandler 38th Annual Healthcare Conference in New York on Dec. 2.
